Simplex Trading, LLC Ardelyx, Inc. Transaction History

Simplex Trading, LLC

$3.28 Billion
Q4 2024

A detailed history of Simplex Trading, LLC transactions in Ardelyx, Inc. stock. As of the latest transaction made, Simplex Trading, LLC holds 169,863 shares of ARDX stock, worth $905,369. This represents 0.03% of its overall portfolio holdings.

Number of Shares

169,863

Previous 240,199 29.28%

Holding current value

$905,369

Previous $1.65 Million 46.92%

% of portfolio

0.03%

Previous 0.06%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 11, 2025	SELL	$4.49 - $6.85 $315,808 - $481,801	-70,336 Reduced 29.28%	169,863 $878,000
Q3 2024 Nov 08, 2024	SELL	$5.28 - $7.57 $384,373 - $551,080	-72,798 Reduced 23.26%	240,199 $1.65 Million
Q2 2024 Jul 25, 2024	BUY	$5.89 - $9.31 $1 Million - $1.59 Million	170,348 Added 119.42%	312,997 $2.32 Million
Q1 2024 Apr 25, 2024	SELL	$6.05 - $9.74 $1.56 Million - $2.51 Million	-258,030 Reduced 64.4%	142,649 $1.04 Million
Q4 2023 Feb 02, 2024	BUY	$3.29 - $6.64 $808,379 - $1.63 Million	245,708 Added 158.55%	400,679 $2.48 Million
Q3 2023 Nov 01, 2023	BUY	$3.3 - $4.83 $191,502 - $280,289	58,031 Added 59.86%	154,971 $632,000
Q2 2023 Aug 04, 2023	BUY	$3.23 - $4.95 $313,116 - $479,853	96,940 New	96,940 $328,000
Q4 2022 Feb 02, 2023	SELL	$1.22 - $2.85 $96,997 - $226,592	-79,506 Reduced 48.31%	85,055 $242,000
Q3 2022 Nov 04, 2022	SELL	$0.59 - $1.44 $176,635 - $431,111	-299,383 Reduced 64.53%	164,561 $195,000
Q2 2022 Aug 03, 2022	BUY	$0.51 - $1.17 $108,809 - $249,621	213,352 Added 85.14%	463,944 $273,000
Q1 2022 May 02, 2022	BUY	$0.65 - $1.18 $29,203 - $53,015	44,928 Added 21.85%	250,592 $268,000
Q4 2021 Feb 23, 2022	BUY	$0.86 - $1.7 $153,632 - $303,693	178,643 Added 661.13%	205,664 $226,000
Q3 2021 Oct 28, 2021	BUY	$1.27 - $8.17 $12,861 - $82,737	10,127 Added 59.94%	27,021 $214,000
Q2 2021 Aug 12, 2021	BUY	$6.55 - $8.98 $41,140 - $56,403	6,281 Added 59.18%	16,894 $128,000
Q1 2021 Apr 26, 2021	SELL	$6.1 - $7.69 $229,311 - $289,082	-37,592 Reduced 77.98%	10,613 $70,000
Q4 2020 Feb 02, 2021	BUY	$5.05 - $7.1 $243,435 - $342,255	48,205 New	48,205 $311,000
Q3 2020 Oct 14, 2020	SELL	$5.25 - $7.08 $20,307 - $27,385	-3,868 Closed	0 $0
Q2 2020 Jul 13, 2020	SELL	$5.37 - $8.11 $44,323 - $66,939	-8,254 Reduced 68.09%	3,868 $26,000
Q1 2020 Apr 29, 2020	SELL	$4.35 - $8.79 $68,803 - $139,031	-15,817 Reduced 56.61%	12,122 $68,000
Q4 2019 Feb 05, 2020	BUY	$4.23 - $8.29 $118,181 - $231,614	27,939 New	27,939 $209,000
Q1 2019 Apr 18, 2019	SELL	$1.88 - $3.35 $3,801 - $6,773	-2,022 Closed	0 $0
Q4 2018 Jan 16, 2019	BUY	$1.66 - $4.16 $3,356 - $8,411	2,022 New	2,022 $3,000
Q3 2018 Oct 23, 2018	SELL	$3.75 - $4.65 $7,248 - $8,988	-1,933 Closed	0 $0
Q2 2018 Jul 30, 2018	BUY	$3.7 - $5.8 $6,778 - $10,625	1,832 Added 1813.86%	1,933 $7,000
Q1 2018 Apr 26, 2018	SELL	$5.05 - $7.9 $31,375 - $49,082	-6,213 Reduced 98.4%	101 $0
Q4 2017 Jan 10, 2018	BUY	$4.85 - $7.8 $6,484 - $10,428	1,337 Added 26.86%	6,314 $41,000
Q3 2017 Oct 25, 2017	BUY	$4.35 - $5.7 $21,649 - $28,368	4,977	4,977 $27,000

Others Institutions Holding ARDX

# of Institutions

233

Shares Held

150M

Call Options Held

1.54M

Put Options Held

3.08M

View Full List

About ARDELYX, INC.

Ticker ARDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 154,636,000
Market Cap $824M
Description
Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...

More about ARDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.

Account

Simplex Trading, LLC Ardelyx, Inc. Transaction History